COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,003 Articles (22,627 medRxiv, 8,376 bioRxiv)

Most recent first Previous |  Page 1603: Articles 16021-16030  | Next

Real-world Effect of Monoclonal Antibody Treatment in COVID-19 Patients in a Diverse Population in the United States
Rainwater-Lovett, K., Redd, J. T., Stewart, M. A., Elias Calles, N., Cluff, T., Fang, M., Panaggio, M. J., Lambrou, A. S., Thornhill, J. K., Bradburne, C., Imbriale, S., Freeman, J. D., Anderson, M., Kadlec, R. P.
10.1101/2021.04.08.21254705 — Posted: 2021-04-10
Convalescent Plasma Use in the United States was inversely correlated with COVID-19 Mortality: Did Convalescent Plasma Hesitancy cost lives?
Casadevall, A., Dragotakes, Q., Johnson, P. W., Senefeld, J. W., Klassen, S. S., Wright, S. R., Joyner, M. J., Paneth, N., Carter, R.
10.1101/2021.04.07.21255089 — Posted: 2021-04-10
Modelling the impact of extending dose intervals for COVID-19 vaccines in Canada
Nam, A., Ximenes, R., Yeung, M. W., Mishra, S., Wu, J., Tunis, M., Sander, B.
10.1101/2021.04.07.21255094 — Posted: 2021-04-10
Direct and indirect effectiveness of mRNA vaccination against SARS-CoV-2 infection in long-term care facilities in Spain
Monge, S., Olmedo, C., Alejos, B., Lapena, M., Sierra, M. J., Limia, A.
10.1101/2021.04.08.21255055 — Posted: 2021-04-10 Discussion: Onsite
Bead-assisted SARS-CoV-2 multi-antigen serological test allows effective identification of patients
Caceres-Martell, Y., Fernandez-Soto, D., Campos-Silva, C., Garcia-Cuesta, E. M., Casasnovas, J. M., Navas-Herrera, D., Beneitez-Martinez, A., Martinez-Fleta, P., Alfranca, A., Sanchez-Madrid, F., Escudero-Lopez, G., Vilches, C., Jara-Acevedo, R., Reyburn, H. T., Rodriguez-Frade, J. M., Vales-Gomez, M.
10.1101/2021.04.08.21254348 — Posted: 2021-04-10
Impact of the COVID-19 pandemic and response on the utilisation of health services during the first wave in Kinshasa, the Democratic Republic of the Congo
Hategeka, C., Carter, S. E., Chenge, F. M., Katanga, E. N., Lurton, G., Mayaka, S. M.-N., Mwamba, D. K., van Kleef, E., Vanlerberghe, V., Grepin, K. A.
10.1101/2021.04.08.21255096 — Posted: 2021-04-10
Who funded the research behind the Oxford-AstraZeneca COVID-19 vaccine? - Approximating the funding to the University of Oxford for the research and development of the ChAdOx vaccine technology
Cross, S., Rho, Y., Reddy, H., Pepperrell, T., Rodgers, F., Osborne, R., Eni-Olotu, A., Banerjee, R., Wimmer, S., Keestra, S. M.
10.1101/2021.04.08.21255103 — Posted: 2021-04-10 Discussion: Onsite
North West London Covid-19 Vaccination Programme: Real-world evidence for Vaccine uptake and effectiveness.
Glampson, B., Brittain, J., Kaura, A., Mulla, A., Mercuri, L., Brett, S., Aylin, P., Sandall, T., Goodman, I., Redhead, J., Saravanakumar, K., Mayer, E.
10.1101/2021.04.08.21254580 — Posted: 2021-04-10
Atypical N-glycosylation of SARS-CoV-2 impairs the efficient binding of Spike-RBM to the human-host receptor hACE2
Gamez, G., Hermoso, J. A., Carrasco-Lopez, C., Gomez Mejia, A., Muskus, C., Hammerschmidt, S.
10.1101/2021.04.09.439154 — Posted: 2021-04-10
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques
King, H. A. D., Joyce, M. G., Elakhal Naouar, I., Ahmed, A., Macedo Cincotta, C., Subra, C., Peachman, K. K., Hack, H. H., Chen, R. E., Thomas, P. V., Chen, W.-H., Sankhala, R. S., Hajduczki, A., Martinez, E. J., Peterson, C. E., Chang, W. C., Choe, M., Smith, C., Headley, J. A., Elyard, H. A., Cook, A., Anderson, A., Wuertz, K. M., Dong, M., Swafford, I., Case, J. B., Currier, J. R., Lal, K. G., Amare, M. F., Dussupt, V., Molnar, S., Daye, S. P., Zeng, X., Barkei, E. K., Alfson, K., Staples, H. M., Carrion, R., Krebs, S. J., Paquin-Proulx, D., Karasavvas, N., Polonis, V. R., Jagodzinski, L. L., Vasan, S., Scott, P. T., Huang, Y., Nair, M. S., Ho, D. D., de Val, N., Diamond, M. S., Lewis, M. G., Rao, M., Matyas, G. R., Gromowski, G. D., Peel, S. A., Michael, N. L., Modjarrad, K., Bolton, D. L.
10.1101/2021.04.09.439166 — Posted: 2021-04-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).